Dr. Reddy's Laboratories Limited
RDY
NYSE
14.67
USD-0.04(-0.27%)
As of today
Dr. Reddy's Laboratories Limited fundamentals
Key ratios
Statements Highlights
| Period Ending | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | Mar 31, 2025 | |
|---|---|---|---|---|---|---|
| Total Revenue | 189,722,000,000 | 214,391,000,000 | 245,879,000,000 | 279,164,000,000 | 325,535,000,000 | |
| Gross Profit | 103,077,000,000 | 113,840,000,000 | 202,972,000,000 | 163,607,000,000 | 190,428,000,000 | |
| Operating Income | 36,062,000,000 | 40,818,000,000 | 96,282,000,000 | 67,729,000,000 | 71,843,000,000 | |
| Net Income | 17,238,000,000 | 23,568,000,000 | 45,067,000,000 | 55,684,000,000 | 56,544,000,000 | |
| Total Assets | 265,491,000,000 | 296,654,000,000 | 322,851,000,000 | 387,518,000,000 | 492,989,000,000 | |
| Total Current Liabilities | 81,472,000,000 | 97,842,000,000 | 85,721,000,000 | 96,039,000,000 | 130,392,000,000 | |
| Total Equity | 174,981,000,000 | 190,527,000,000 | 232,861,000,000 | 280,550,000,000 | 337,166,000,000 | |
| Free Cash Flow | 23,142,000,000 | 9,059,000,000 | 40,009,000,000 | 17,998,000,000 | 12,030,000,000 | |
| Cash from Operations | 35,703,000,000 | 28,108,000,000 | 58,873,000,000 | 45,433,000,000 | 46,428,000,000 | |
| Cash from Investing | -22,660,000,000 | -26,387,000,000 | -41,371,000,000 | -40,283,000,000 | -58,077,000,000 | |
| Cash from Financing | -298,000,000 | -2,422,000,000 | -26,861,000,000 | -3,763,000,000 | 18,911,000,000 | |
| Net Change in Cash | 12,858,000,000 | 32,000,000 | -9,073,000,000 | 1,328,000,000 | 7,486,000,000 |